In this Issue:
Tocilizumab in systemic sclerosis: FASSCINATE trial
A synerkine of IL4 and IL10 for inflammatory disorders
Immune reconstitution post-AHSCT in systemic sclerosis
Pregnancy outcomes in RA patients with bDMARD exposure
…and in patients exposed to certolizumab pegol
Baricitinib in active RA with inadequate response to anti-TNFs
Ustekinumab and guselkumab in active RA
Clinical remission and serum levels of tocilizumab in RA
Tocilizumab in early RA: U-ACT-EARLY study
Overlap of classification criteria for fibromyalgia & axial spondyloarthritis
Please login below to download this issue (PDF)